Qi Cui, MD, PhD — GLP-1R: A New Frontier in Glaucoma Treatment

This recorded webinar from September 18, 2025 features Qi Cui, MD, PhD, Associate Professor of Ophthalmology and Associate Residency Program Director of Research at the University of Pennsylvania, who shares insights into her research on the potential of GLP-1 receptor (GLP-1R)–based therapies as a novel potential treatment pathway for glaucoma. Moderated by Cynthia Steel, PhD, Chief Scientific Officer for Glaucoma Research Foundation.

This Innovations in Glaucoma Webinar contains forward-looking statements about glaucoma treatments that are not yet available for patients. At Glaucoma Research Foundation (GRF) we are optimistic about the potential for new treatments that could make possible a more personalized approach to the management of glaucoma and may significantly improve quality of life for glaucoma patients. Results in early-stage clinical trials may not be indicative of full results or results from later stage, larger scale clinical trials, and do not ensure regulatory approval. The views and opinions expressed by the speakers are provided for educational purposes and do not necessarily represent the views of Glaucoma Research Foundation.